Note: Ingredients listed on restricted chemical lists
EC/CAS
203-961-6/112-34-5
Name of the chemical
2-(2-butoxyethoxy)ethanol
Concentration
10 - 25
EC/CAS
203-815-1/110-91-8
Name of the chemical
Morpholine
Concentration
<0.05
General Information
Version
4.0
Revision date
2024-06-24
Product name
JetFoam 3%
1.2.1 Relevant identified uses
Industrial use,Professional use Industrial/Professional use spec Industrial
Emergency telephone
+44(0) 1524 264000, 0344 892 0111
Icons in SDS
Company Information
company name
ANGUS FIRE Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
general.enquiries@angus.co.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS05
Signal word
Danger
Contains
Dodecyldimethylamine oxide; Sulfuric acid, mono-C12-14-alkylesters, sodium salts
Hazard statements
H318 - Causes serious eye damage.
Precautionary statements
P280 - Wear eye protection, protective clothing, protective gloves. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a doctor.
PBT Substances
not relevant – no registration required
vPvB Substances
not relevant – no registration required Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH 2-(2-butoxyethoxy)ethanol (112-34-5), Sulfuric acid, mono-C12-14-alkylesters, sodium regulation, in accordance with Annex XIII salts (85586-07-8), Morpholine (110-91-8)(¹) Substance(s) not meeting the vPvB criteria of REACH 2-(2-butoxyethoxy)ethanol (112-34-5), Sulfuric acid, mono-C12-14-alkylesters, sodium regulation, in accordance with Annex XIII salts (85586-07-8), Morpholine (110-91-8)(¹) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 1 H318 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
